{"id":62054,"date":"2025-01-01T00:00:00","date_gmt":"2025-01-01T00:00:00","guid":{"rendered":"https:\/\/ibima.eu\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/"},"modified":"2025-01-01T00:00:00","modified_gmt":"2025-01-01T00:00:00","slug":"effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season","status":"publish","type":"post","link":"https:\/\/ibima.eu\/es\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/","title":{"rendered":"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season"},"content":{"rendered":"<p>N\u00fa\u00f1ez, O; Olmedo, C; Moreno-Perez, D; Lorusso, N; Mart\u00ednez, SF; Villalba, PEP; Gutierrez, A; Garcia, MA; Latasa, P; Sancho, R; Mendioroz, J; Martinez-Marcos, M; Plat\u00f3n, EM; Rivera, MVG; Perez-Martinez, O; alvarez-Gil, R; Wagner, ER; Gonzalez-Coviella, NL; Zornoza, M; Barranco, MI; Pacheco, MD; R\u00edo, VA; Jaume, MF; Arance, RM; Sancho, BA; Diaz, MM; Batalla, N; Andreu, C; Castilla, J; Cenoz, MG; Ib\u00e1\u00f1ez, AF; Huerta, MH; P\u00e9rez, ACI; S\u00e1enz, BB; Lamas, J; Hermoso, L; Cobo, SC; Cuesta, MG; Montenegro, S; Dom\u00ednguez, M; Jarr\u00edn, I; Limia, A; Pastor-Barriuso, R; Monge, S &#8211; 2025 &#8211; 10.2807\/1560-7917.ES.2025.30.5.2400596<\/p>\n","protected":false},"excerpt":{"rendered":"<p>N\u00fa\u00f1ez, O; Olmedo, C; Moreno-Perez, D; Lorusso, N; Mart\u00ednez, SF; Villalba, PEP; Gutierrez, A; Garcia, MA; Latasa, P; Sancho, R; Mendioroz, J; Martinez-Marcos, M; Plat\u00f3n, EM; Rivera, MVG; Perez-Martinez, O; alvarez-Gil, R; Wagner, ER; Gonzalez-Coviella, NL; Zornoza, M; Barranco, MI; Pacheco, MD; R\u00edo, VA; Jaume, MF; Arance, RM; Sancho, BA; Diaz, MM; Batalla, N; Andreu, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1585],"tags":[],"class_list":["post-62054","post","type-post","status-publish","format-standard","hentry","category-publicaciones-a-19"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/es\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season - Ibima\" \/>\n<meta property=\"og:description\" content=\"N\u00fa\u00f1ez, O; Olmedo, C; Moreno-Perez, D; Lorusso, N; Mart\u00ednez, SF; Villalba, PEP; Gutierrez, A; Garcia, MA; Latasa, P; Sancho, R; Mendioroz, J; Martinez-Marcos, M; Plat\u00f3n, EM; Rivera, MVG; Perez-Martinez, O; alvarez-Gil, R; Wagner, ER; Gonzalez-Coviella, NL; Zornoza, M; Barranco, MI; Pacheco, MD; R\u00edo, VA; Jaume, MF; Arance, RM; Sancho, BA; Diaz, MM; Batalla, N; Andreu, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/es\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-01T00:00:00+00:00\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\\\/\"},\"author\":{\"name\":\"prodriguez\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"headline\":\"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\\\/24 season\",\"datePublished\":\"2025-01-01T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\\\/\"},\"wordCount\":124,\"articleSection\":[\"Publicaciones - A-19\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\\\/\",\"name\":\"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\\\/24 season - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"datePublished\":\"2025-01-01T00:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\\\/24 season\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\",\"name\":\"prodriguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"caption\":\"prodriguez\"},\"sameAs\":[\"https:\\\/\\\/ibima.eu\"],\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/author\\\/prodriguez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/es\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/","og_locale":"es_ES","og_type":"article","og_title":"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season - Ibima","og_description":"N\u00fa\u00f1ez, O; Olmedo, C; Moreno-Perez, D; Lorusso, N; Mart\u00ednez, SF; Villalba, PEP; Gutierrez, A; Garcia, MA; Latasa, P; Sancho, R; Mendioroz, J; Martinez-Marcos, M; Plat\u00f3n, EM; Rivera, MVG; Perez-Martinez, O; alvarez-Gil, R; Wagner, ER; Gonzalez-Coviella, NL; Zornoza, M; Barranco, MI; Pacheco, MD; R\u00edo, VA; Jaume, MF; Arance, RM; Sancho, BA; Diaz, MM; Batalla, N; Andreu, [&hellip;]","og_url":"https:\/\/ibima.eu\/es\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/","og_site_name":"Ibima","article_published_time":"2025-01-01T00:00:00+00:00","author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"prodriguez","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/"},"author":{"name":"prodriguez","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"headline":"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season","datePublished":"2025-01-01T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/"},"wordCount":124,"articleSection":["Publicaciones - A-19"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/","url":"https:\/\/ibima.eu\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/","name":"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2025-01-01T00:00:00+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"breadcrumb":{"@id":"https:\/\/ibima.eu\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/effectiveness-of-catch-up-and-at-birth-nirsevimab-immunisation-against-rsv-hospital-admission-in-the-first-year-of-life-a-population-based-case-control-study-spain-2023-24-season\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case-control study, Spain, 2023\/24 season"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635","name":"prodriguez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","caption":"prodriguez"},"sameAs":["https:\/\/ibima.eu"],"url":"https:\/\/ibima.eu\/es\/author\/prodriguez\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/62054","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/comments?post=62054"}],"version-history":[{"count":0,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/posts\/62054\/revisions"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/media?parent=62054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/categories?post=62054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/tags?post=62054"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}